We are live on ! Find out more
ERNA icon

Eterna Therapeutics

6 hedge funds and large institutions have $2.66M invested in Eterna Therapeutics in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

13% less capital invested

Capital invested by funds: $3.04M → $2.66M (-$380K)

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

ERNA Hedge Fund Activity: Q1 2016 in Review

6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2016, worth a combined $2.66M — down 13% from $3.04M a quarter earlier.

Fund positioning in ERNA was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Virtu KCG Holdings, cutting an estimated $11K.

  • 6 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $2.66M of Eterna Therapeutics stock for Q1 2016, down 13% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q1 2016 and 0 closed out.
  • The largest Eterna Therapeutics seller in Q1 2016 was Virtu KCG Holdings, an estimated $11K sold.

Based on aggregated 13F filings for Q1 2016.